Elite Pharmaceuticals Market Cap

Elite Pharmaceuticals has a market cap or net worth of $567.50 million as of August 14, 2025. Its market cap has increased by 177.26% in one year.

Market Cap

567.50M

Enterprise Value

567.10M

Revenue

84.04M

Ranking

n/a

PE Ratio

n/a

Stock Price

$0.52

Market Cap Chart

Since July 23, 1998, Elite Pharmaceuticals's market cap has increased from 9.58M to 567.50M, an increase of 5,826.80%. That is a compound annual growth rate of 16.27%.

Market Cap History

Date	Market Cap	% Change
Aug 13, 2025	567.50M	-1.82%
Dec 31, 2024	578.04M	306.60%
Dec 29, 2023	142.16M	374.74%
Dec 30, 2022	29.95M	-10.40%
Dec 31, 2021	33.42M	-36.49%
Dec 31, 2020	52.63M	-31.72%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Nika Pharmaceuticals	972.72M
Veradigm	789.71M
Tian'an Technology Group	628.15M
Glass House Brands	543.74M
American Oncology Network	393.37M
Northwest Biotherapeutics	332.06M
CytoDyn	300.87M
Alterola Biotech	296.25M

Market Cap Rankings